| Completed | Persistency Study After Hib-CRM (Cross-Reacting Material)197 or Hib-TT (Tetanus Toxoid) Vaccines in Chinese Ch Meningitis, Epiglottitis, Pneumonia, Arthritis Caused by Haemophilus Influenzae Type b | Phase 3 | 2014-11-01 |
| Completed | Safety and Immunogenicity of an Adjuvanted Trivalent Influenza Vaccine in Children 6 to <72 Months of Age in M Influenza | Phase 3 | 2014-10-01 |
| Completed | Safety and Immunogenicity of Two Trivalent Subunit Influenza Vaccines in Healthy Adult Subjects Prophylaxis: Influenza | Phase 3 | 2014-09-01 |
| Completed | Effectiveness, Immunogenicity and Safety of Meningococcal ABCWY Vaccine Administered to Healthy Adolescents Meningococcal Disease | Phase 2 | 2014-05-01 |
| Completed | Phase 2, Observer-Blind, Placebo-Controlled, Randomized, Multi-Center Extension Study to Evaluate the Safety a Meningococcal Disease | Phase 2 | 2013-12-01 |
| Completed | Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older Influenza | Phase 3 | 2013-11-01 |
| Completed | Safety and Immunogenicity of One Dose of Novartis' Meningococcal ACWY-CRM Vaccine and GlaxoSmithKline Biologic Meningococcal Disease | Phase 2 | 2013-11-01 |
| Completed | Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old Influenza | Phase 3 | 2013-11-01 |
| Completed | Safety and Immunogenicity Study of Two Doses of Novartis Meningococcal Serogroup B Recombinant Vaccine in Adol Meningococcal Disease | Phase 3 | 2013-11-01 |
| Completed | A Study to Evaluate the Safety of Two Influenza Vaccines in Children and Adolescents 3 to <18 Years of Age at Influenza | Phase 3 | 2013-10-01 |
| Completed | Burden of Invasive Group B Streptococcal (GBS) Disease in Young Infants in China Invasive Group B Streptococcal Disease | — | 2013-09-01 |
| Completed | Safety and Immunogenicity of One Dose of Seasonal Trivalent Influenza Virus Vaccine (TIVf, Purified Surface An Human Influenza | Phase 3 | 2013-08-01 |
| Completed | A Phase 3b, Single-Center, Open-label Study to Assess the Immunogenicity and Safety of Novartis Meningococcal Prevention of the Meningococcal Disease | Phase 3 | 2013-08-01 |
| Completed | Dose-finding Study of Four Dosage Levels of an H7N9 Influenza Vaccine in Adults Between Ages of 18 Years and 6 H7N9 Influenza | Phase 1 | 2013-08-01 |
| Completed | Safety and Immunogenicity of a Cell Derived Subunit Trivalent Nonadjuvanted Influenza Study Vaccine in Adults Human Influenza | Phase 3 | 2013-08-01 |
| Completed | Safety and Immunogenicity of a Subunit Trivalent Influenza Vaccine, Northern Hemisphere Formulation 2013/2014, Human Influenza | Phase 2 | 2013-07-01 |
| Completed | Safety and Immunogenicity of a Subunit Trivalent Influenza Vaccine, Northern Hemisphere Formulation 2013/2014, Human Influenza | Phase 2 | 2013-07-01 |
| Completed | Antibody Persistence, and Safety and Tolerability of a Booster Dose of the Meningococcal B Vaccine After the C Meningoccocal Disease, Meningococcal Meningitis | Phase 3 | 2013-06-01 |
| Completed | A Phase 3b Study to Assess the Safety of Novartis Meningococcal B Recombinant Vaccine When Administered in Hea Meningococcal Disease, Meningococcal Meningitis | Phase 3 | 2013-05-01 |
| Completed | Safety of Two Trivalent Influenza Vaccines Evaluated in Children and Adolescents 4 to 17 Years of Age Influenza, Fever | Phase 3 | 2013-05-01 |
| Completed | Safety and Immunogenicity of Three Dosage Levels of Swine Influenza Vaccine in Children Ages 3 to <9 Years, Ad Prophylaxis of A/H3N2v Influenza | Phase 1 | 2013-05-01 |
| Completed | Persistence of Immunogenicity of MenACWY Conjugate Vaccine 5 Years After Childhood Vaccination, and Immune Res Meningococcal Disease | Phase 4 | 2013-05-01 |
| Withdrawn | Safety of One Dose of Meningococcal ACWY Conjugate Vaccine in Subjects 2 Years of Age and Older Meningococcal Disease | — | 2013-03-01 |
| Completed | Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Elderly Subjects Pandemic H5N1 Influenza | Phase 2 | 2013-01-01 |
| Completed | Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Children Pandemic H5N1 Influenza | Phase 2 | 2013-01-01 |
| Completed | Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Healthy Adults Pandemic H5N1 Influenza | Phase 2 | 2013-01-01 |
| Completed | Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Children, Adolescents and Adults Meningococcal Disease | Phase 3 | 2012-11-01 |
| Completed | Study to Identify Factors Influencing Access of Pregnant Women and Their Infants to Local Healthcare Systems Pregnancy, Newborn Health | — | 2012-11-01 |
| Completed | Persistence of Antibody Levels and Response to Fifth or Third Meningococcal B Recombinant Vaccine in 4-year Ol Meningococcal Disease, Meningococcal Meningitis | Phase 3 | 2012-11-01 |
| Completed | A Randomized, Open-label Study Comparing Two Different Rabies Vaccine Schedules in Chinese Children and Older Rabies | Phase 3 | 2012-09-01 |
| Completed | Safety and Immunogenicity of 2 Different Vaccination Schedules of Rabies and Japanese Encephalitis Vaccines in Rabies, Japanese Encephalitis | Phase 3 | 2012-08-01 |
| Completed | Safety and Immunogenicity of One Dose of Seasonal Trivalent Influenza Virus Vaccine (TIVf, Purified Surface An Human, Influenza | Phase 3 | 2012-07-01 |
| Completed | Safety and Immunogenicity of a Trivalent Influenza Vaccine When Administered to Elderly Subjects Human Influenza | Phase 2 | 2012-07-01 |
| Completed | Safety and Immunogenicity of a Subunit Trivalent Nonadjuvated Influenza Study Vaccine in Adults Aged 18 Years Human Influenza | Phase 2 | 2012-07-01 |
| Completed | Safety and Immunogenicity of a Cell Derived Subunit Trivalent Nonadjuvated Influenza Study Vaccine in Adults A Influenza | Phase 3 | 2012-07-01 |
| Completed | Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vacci Pertussis, Whooping Cough, Tetanus | Phase 1 | 2012-03-01 |
| Completed | Immunogenicity, Safety and Tolerability of a Fully Liquid Pentavalent (DTwP-Hib-Hep B) Vaccine in Infants 6-8 Diphtheria, Tetanus, Pertussis | Phase 3 | 2011-12-01 |
| Completed | Study to Evaluate the Safety and Immunogenicity of Combined Hepatitis A/B Vaccine With MenACWY-CRM Conjugate V Meningococcal Disease, Meningococcal Meningitis, Hepatitis A | Phase 3 | 2011-10-01 |
| Completed | Safety of MenACWY-CRM Vaccination in Adolescents Meningococcal Disease | — | 2011-09-01 |
| Completed | Safety and Immunogenicity of One Dose of a Surface, Antigen, Inactivated, Influenza Vaccine Produced in Mammal Influenza | Phase 3 | 2011-09-01 |
| Completed | Safety Surveillance of MenACWY-CRM Vaccine in Children Meningococcal Disease | — | 2011-09-01 |
| Completed | Magnitude of the Antibody Response to and Safety of a GBS Trivalent Vaccine in HIV Positive and HIV Negative P Streptococcal Infections, Gram-Positive Bacterial Infections, Bacterial Infections | Phase 2 | 2011-09-01 |
| Completed | Safety of Haemophilus Influenza Type b Vaccine When Administered to Korean Children Haemophilus Influenzae Type B Infection | Phase 4 | 2011-08-01 |
| Completed | Safety and Immunogenicity of Different Meningitis Vaccine Formulations in Adolescents and Young Adults Invasive Meningococcal Disease | Phase 2 | 2011-08-01 |
| Completed | Safety, Tolerability and Immunogenicity of a Third Dose of One of Four Different Formulations of rMenB + MenAC Meningococcal Disease, Meningococcal Meningitis | Phase 2 | 2011-07-01 |
| Completed | Immunogenicity and Safety of Rabies Vaccine, Administered With Two Different Simulated Post Exposure Schedules Rabies | Phase 4 | 2011-07-01 |
| Completed | Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine or Meningococcal Disease | Phase 3 | 2011-05-01 |
| Completed | Safety and Immunogenicity of One Dose of an Inactivated Trivalent Sub-unit Influenza Vaccine Administered to N Influenza | Phase 2 | 2011-05-01 |
| Completed | Humoral and Cell Mediated Immunity and Safety of MF59C.1-adjuvanted Subunit Influenza Vaccine or a Conventiona Seasonal Influenza, Influenza, Influenza Due to Unspecified Influenza Virus | Phase 2 | 2011-05-01 |
| Completed | Study to Evaluate Safety and Immunogenicity of Sub-unit Adjuvanted Influenza Vaccine Administered to Elderly S Seasonal Influenza | Phase 2 | 2011-05-01 |
| Completed | Safety, Tolerability, and Immunogenicity of the Adjuvanted Trivalent Subunit Influenza Vaccine and the Non-Adj Influenza Disease | Phase 3 | 2011-04-01 |
| Completed | A Phase 3B, Open Label, Multi-Center Study to Evaluate the Safety, Tolerability and Immunogenicity of Novartis Meningococcal Disease, Meningococcal Meningitis | Phase 3 | 2011-04-01 |
| Completed | A Multi-center, Observer-blind, Placebo-controlled, Randomized Study to Evaluate the Immunogenicity and Safety Meningococcal Disease, Meningococcal Meningitis | Phase 3 | 2010-12-01 |
| Completed | Immunogenicity and Safety of Different rMenB Plus MenACWY Formulations in Adolescents Meningococcal Disease, Meningococcal Meningitis | Phase 2 | 2010-12-01 |
| Completed | Immunogenicity and Safety of a Booster Dose of Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hi Haemophilus Influenzae Type b (Hib) Infection | Phase 3 | 2010-10-01 |
| Completed | Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non Pregnant and Pregnant Women 18-40 Years of Streptococcal Infections | Phase 1 / Phase 2 | 2010-10-01 |
| Completed | Safety and Immunogenicity of 2 or 3 Doses of MenACWY Conjugate Vaccine in Healthy Infants and the Effects of a Meningococcal Disease, Meningococcal Meningitis | Phase 3 | 2010-10-01 |
| Completed | A Post-marketing Study to Monitor the Safety of a MF59-adjuvanted Influenza Vaccine Administered in Korean Sub Influenza | Phase 4 | 2010-10-01 |
| Completed | Safety and Immunogenicity of Trivalent Subunit Inactivated Flu Vaccine Administered to Healthy Children and Ad Seasonal Influenza | Phase 3 | 2010-09-01 |
| Completed | Novartis Vaccine and Diagnostics Carriage Trial N. Meningitidis Carriage | Phase 3 | 2010-09-01 |
| Completed | Immunogenicity and Safety of V70P5 Revaccination Subjects Influenza | Phase 3 | 2010-09-01 |
| Completed | Safety and Immunogenicity of MF59C.1 Adjuvanted Trivalent Subunit Influenza Vaccine in Elderly Subjects Influenza | Phase 3 | 2010-08-01 |
| Completed | Assessment of Antibody Persistence at Eighteen Months After the Completion of the Vaccination Course in Study Meningococcal Disease, Meningococcal Meningitis | Phase 2 / Phase 3 | 2010-08-01 |
| Completed | Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine Meningococcal Meningitis | Phase 3 | 2010-07-01 |
| Completed | Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2010/2011, W Seasonal Influenza | Phase 3 | 2010-07-01 |
| Completed | One Year Antibody Persistence After a Fourth Dose Boost or Two Catch-Up Doses of Novartis Meningococcal B Reco Meningococcal Disease | Phase 3 | 2010-06-01 |
| Completed | Safety and Immunogenicity of One Dose of Inactivated Trivalent Flu Vaccine Administered to Non-elderly Adult a Seasonal Influenza | Phase 2 | 2010-06-01 |
| Completed | Safety and Immunogenicity, Inactivated Split Influenza Vaccine, Using the Strain Composition 2010/2011 Seasonal Influenza | Phase 3 | 2010-06-01 |
| Completed | Study to Evaluate Safety and Immunogenicity of Sub-unit Adjuvanted Influenza Vaccine Administered to Elderly S Seasonal Influenza | Phase 2 | 2010-06-01 |
| Completed | Safety and Immunogenicity of a Group B Streptococcus Vaccine in Healthy Women Group B Streptococcus | Phase 1 | 2010-05-01 |
| Completed | Study in Infants (6-12 Months) Comparing Two Doses of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -C Haemophilus Influenzae Type b (Hib) Infection | Phase 3 | 2010-04-01 |
| Completed | Open-label, Uncontrolled Postmarketing Study of Cell-derived A/H1N1 Influenza HA Vaccine in Japanese Elderly S Swine-Origin Influenza A H1N1 Virus | Phase 4 | 2010-03-01 |
| Completed | Drug Use Investigation for Cell-culture Derived Influenza A (H1N1) Emulsion HA Vaccine Swine-Origin Influenza A H1N1 Virus | — | 2010-02-01 |
| Completed | Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of a Booster Dose Meningococcal Disease | Phase 2 | 2010-02-01 |
| Completed | Evaluating the Safeness of Trivalent Subunit Inactivated Influenza Vaccines in Preventing Flu on Vietnamese Vo Seasonal Influenza | Phase 2 | 2010-01-01 |
| Completed | Novartis Pandemic Influenza A (H1N1) Vaccine(s) Observational Comparative Safety Study Influenza | — | 2010-01-01 |
| Completed | A Study to Assess the Persistence of Two GBS Antibodies in Women Previously Immunized With a GBS Vaccine Group B Streptococcus (GBS) Disease | Phase 1 | 2010-01-01 |
| Terminated | Single Center, Open Label, Follow up Study in Subjects Who Previously Received Rabies Vaccine as Simulated Pos Rabies | — | 2010-01-01 |
| Completed | A Study to Evaluate the Persistence and Immune Response to a Booster Dose of MenACWY Meningococcal Disease, Meningococcal Meningitis | Phase 2 | 2010-01-01 |
| Completed | Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of Booster Doses o Meningococcal Disease | Phase 2 | 2010-01-01 |
| Completed | Observational Study of Safety of Flu Cell Culture Derived Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Va Novel Influenza A (H1N1), A New Flu Virus of Swine Origin | — | 2009-12-01 |
| Completed | Observational Safety Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine Pandemic Influenza A (H1N1), A New Flu Virus of Swine Origin | — | 2009-12-01 |
| Completed | A Study to Evaluate the Safety and Immunogenicity of 4 Doses of MenACWY Conjugate Vaccine, Administered Concom Meningococcal Disease | Phase 3 | 2009-11-01 |
| Completed | Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Pediatric Subjects Swine-Origin Influenza A H1N1 Virus | Phase 2 / Phase 3 | 2009-10-01 |
| Completed | Observational Safety and Effectiveness Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Influenza A (H1N1) | — | 2009-10-01 |
| Completed | Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1)2009 Monovalent Subunit Vaccine Wi Influenza | Phase 2 / Phase 3 | 2009-10-01 |
| Completed | Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Adult Subjects Influenza | Phase 2 / Phase 3 | 2009-09-01 |
| Completed | Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children (3 to < 9 Y Influenza | Phase 2 / Phase 3 | 2009-09-01 |
| Completed | Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Mono Pandemic Influenza | Phase 3 | 2009-09-01 |
| Completed | Study in Toddlers (12-18 Months) Comparing a Booster Dose of Vaxem Hib and Hiberix Vaccines for the Prevention Haemophilus Influenzae Type b (Hib) Infection | Phase 3 | 2009-09-01 |
| Completed | Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two Monovalent H5N1 Influenza Vacci Pandemic H5N1 Influenza | Phase 2 | 2009-09-01 |
| Completed | Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Mono Pandemic Influenza | Phase 3 | 2009-08-01 |
| Completed | Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Mono Pandemic Influenza | Phase 3 | 2009-08-01 |
| Completed | Immunogenicity, Tolerability and Safety of One or Two Doses of an Adjuvanted Swine-origin A H1N1 Influenza Vac Pandemic Influenza Disease | Phase 2 | 2009-08-01 |
| Completed | Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children, Adolescent Novel 2009 Influenza H1N1 | Phase 3 | 2009-08-01 |
| Completed | Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Mono Pandemic Influenza | Phase 3 | 2009-08-01 |
| Completed | Immunogenicity and Safety of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 13- Haemophilus Influenzae Type b (Hib) Infection | Phase 3 | 2009-08-01 |
| Completed | Safety and Immunogenicity in Dose-Ranging and Formulation-Finding Meningococcal B (MenB) Vaccine Study in 2-mo Meningococcal Meningitis, Meningococcal Infections | Phase 2 | 2009-07-01 |
| Completed | Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered as Booster Dose at Meningococcal Disease, Meningococcal Meningitis | Phase 2 / Phase 3 | 2009-07-01 |
| Completed | Safety and Immunogenicity of Surface Antigen, Inactivated, Influenza Vaccine Using the Strain Composition 2009 Influenza Disease | Phase 2 | 2009-06-01 |
| Completed | An Extension Study to Determine the Persistence of Tick-borne Encephalitis (TBE)-Specific Antibody Responses A Tick Borne Encephalitis (TBE) | Phase 4 | 2009-05-01 |
| Completed | Evaluation of Persistence of Anti-meningococcal Bactericidal Antibodies Among Adolescents Who Previously Recei Meningococcal Meningitis | Phase 3 | 2009-02-01 |
| Completed | Extension Study of V72P13 to Evaluate the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Meningococcal Disease | Phase 3 | 2009-02-01 |
| Completed | Safety and Immunogenicity of Two Doses of Monovalent Inactivated Influenza Vaccine That is Adjuvanted With MF5 Prepandemic Influenza Vaccine | Phase 2 | 2008-12-01 |
| Completed | Safety and Immunogenicity (Non-inferiority) of a Purified Chick Embryo Cell Vaccine Vaccine Administered in Tw Rabies | Phase 3 | 2008-11-01 |
| Completed | Safety and Immunogenicity of Two Doses of Monovalent Inactivated Influenza Vaccine That is Adjuvanted With MF5 Pre-pandemic Influenza Vaccine | Phase 3 | 2008-11-01 |
| Completed | Safety and Immunogenicity of a Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type b Haemophilus Influenzae Type b | Phase 3 | 2008-11-01 |
| Completed | Efficacy and Safety of an H.Pylori Vaccine in H.Pylori-Negative Adults Helicobacter Pylori Infection | Phase 1 | 2008-10-01 |
| Completed | Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered With or Without Ro Meningococcal Infections | Phase 2 | 2008-08-01 |
| Completed | Safety and Reactogenicity of a Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type b Haemophilus Influenzae Type b | Phase 1 | 2008-07-01 |
| Completed | Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2008-2009, W Influenza | Phase 2 | 2008-07-01 |
| Completed | Study to Evaluate Safety, Tolerability and Immunogenicity of a Bedside Mixing Combination of Two Adjuvanted In Influenza | Phase 1 | 2008-06-01 |
| Completed | Safety and Immunogenicity of Surface Antigen, Inactivated, Influenza Vaccine Using the Strain Composition 2008 Seasonal Influenza | Phase 2 | 2008-06-01 |
| Completed | Safety and Immunogenicity of Surface Antigen, Inactivated, Adjuvanted With MF59C.1 Influenza Vaccine, Formulat Interpandemic Influenza | Phase 2 | 2008-06-01 |
| Completed | Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine Administered to Health Meningococcal Disease | Phase 2 / Phase 3 | 2008-06-01 |
| Completed | Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2008/2009 Seasonal Influenza, Vaccine | Phase 3 | 2008-06-01 |
| Completed | Safety and Immune Response of Novartis of MenACWY Conjugate Vaccine When Given to Healthy Children Meningococcal Infections | Phase 3 | 2008-03-01 |
| Completed | Safety and Immunogenicity Evaluation After One or Two Doses of Novartis Meningococcal ACWY Conjugate Vaccine i Meningococcal Meningitis | Phase 3 | 2008-03-01 |
| Completed | Immunogenicity, Safety and Lot to Lot Consistency of Novartis Meningococcal B Recombinant Vaccine When Adminis Serogroup B Meningococcal Meningitis | Phase 3 | 2008-03-01 |
| Completed | Safety and Immune Response of Novartis MenACWY-CRM Conjugate Vaccine When Given to Healthy Toddlers Meningococcal Infections | Phase 3 | 2008-02-01 |
| Completed | Evaluation of Meningococcal ACWY Immune Response in Children Aged 40 and 60 Months Meningococcal Disease | Phase 2 | 2008-02-01 |
| Completed | A Phase I, Randomized, Single-blind, Controlled, Single Center Study to Evaluate the Safety and Immunogenicity Invasive Group B Streptococcus (GBS) Disease | Phase 1 | 2008-02-01 |
| Completed | A Phase I, Randomized, Single-blind, Controlled, Single Center Study to Evaluate the Safety and Immunogenicity Invasive Group B Streptococcus (GBS) Disease | Phase 1 | 2007-12-01 |
| Completed | Safety of a Influenza Vaccine Produced Either in Mammalian Cell Culture or in Embryonated Hen Eggs in Adults a Seasonal Influenza, Vaccine | Phase 4 | 2007-11-01 |
| Completed | Safety and Immunogenicity of Two Doses of a Tetravalent Influenza Vaccine in Adults Aged 18 Years and Above Influenza | Phase 2 | 2007-11-01 |
| Completed | Immunogenicity and Safety Following a Single Dose of Influenza Vaccines in Healthy Children Who Received Eithe FLU | Phase 2 | 2007-11-01 |
| Completed | Study to Evaluate the Consistency of Three Consecutive Production Lots of Influenza Vaccine in Healthy Subject Influenza | Phase 3 | 2007-11-01 |
| Completed | Safety and Immunogenicity of a Booster Dose of -H5N1 Influenza Vaccine Avian Influenza | Phase 2 | 2007-10-01 |
| Completed | Efficacy Study of Two Influenza Vaccines and Placebo in Healthy Adult Subjects Influenza | Phase 3 | 2007-10-01 |
| Completed | Immunogenicity, Safety and Tolerability of Two Doses of a Pre-pandemic Influenza Vaccine in Participants Aged Prophylaxis of Avian Influenza | Phase 2 | 2007-09-01 |
| Completed | Immunogenicity of a Surface Antigen, Inactivated Influenza Vaccine Formulation 2007-2008 Influenza | Phase 2 | 2007-07-01 |
| Completed | Safety and Immunogenicity of Trivalent Subunit Influenza Vaccine Produced in Mammalian Cell Culture Using the Seasonal Influenza Vaccine | Phase 3 | 2007-07-01 |
| Completed | A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adolescents Meningococcal Meningitis, Human Papillomavirus Infection, Pertussis | Phase 3 | 2007-07-01 |
| Completed | B Cell Response to a Primary and a Booster Course of the Novartis Meningococcal ACWY Conjugate Vaccine in Heal Meningococcal Disease | Phase 2 | 2007-07-01 |
| Completed | Safety, Tolerability and Immunogenicity of Three Doses of Novartis Meningococcal B Vaccine When Administered t Meningococcal Disease | Phase 2 | 2007-07-01 |
| Completed | Support Annual Strain Update, Safety and Immunogenicity of an Inactivated, Adjuvanted Influenza Vaccine, Formu Influenza Disease | Phase 2 | 2007-06-01 |
| Completed | Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administe Influenza | Phase 2 | 2007-06-01 |
| Completed | Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administe Influenza | Phase 2 | 2007-06-01 |
| Completed | Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Adults Unprimed and Primed With Adjuvanted Prophylaxis of Avian Influenza Vaccine | Phase 2 | 2007-05-01 |
| Completed | A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Healthy Adults Meningococcal Meningitis, Meningococcal Infections | Phase 3 | 2007-05-01 |
| Completed | A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In US Adolesce Meningococcal Infections, Meningococcal Meningitis | Phase 3 | 2007-03-01 |
| Completed | A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants Meningitis, Meningococcal | Phase 3 | 2007-03-01 |
| Completed | Safety, Tolerability and Immunogenicity of Two Different Formulations of Meningococcal B Recombinant Vaccine, Meningococcal Disease | Phase 2 | 2007-02-01 |
| Completed | Safety and Immunogenicity of Two Adjuvanted and One Non-adjuvanted H5N1 Influenza Vaccine in Adults Influenza | Phase 2 | 2006-11-01 |
| Completed | Immunogenicity and Safety of an Adjuvanted Inactivated Subunit Influenza Vaccine to Those of a Non-adjuvanted Influenza Disease | Phase 3 | 2006-11-01 |
| Completed | Safety and Immunogenicity of 2 Commercially Available Influenza Vaccines in Children Influenza | Phase 2 | 2006-11-01 |
| Completed | Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study Healthy | Phase 2 | 2006-09-01 |
| Completed | Safety and Long-term Evaluation (up to 5 Years) of First Booster Immunization With Novartis' TBE Vaccine for A Tick Born Encephalitis | Phase 4 | 2006-09-01 |
| Completed | Safety and Immunogenicity of Meningococcal ACWY Conjugate Versus Polysaccharide Vaccine in Children 2 to 10 Ye Meningococcal Disease | Phase 3 | 2006-05-01 |
| Completed | Persistence of Antibodies and Kinetics of B Cell Response in Healthy Children After Vaccination With MCC Vacci Prevention of Meningococcal Infection | Phase 4 | 2006-04-01 |
| Completed | Immunogenicity and Safety of the Concomitant Administration of a Tdap Vaccine and Meningococcal ACWY Conjugate Meningococcal Disease, Meningococcal Meningitis | Phase 3 | 2006-04-01 |
| Completed | Purified Rabies Vaccine for Human Use (Chick-embryo Cell) Rabies Post-exposure Prophylaxis | Phase 3 | 2006-03-01 |
| Completed | Study of the Safety and Immune Response of Two Serogroup B Meningococcal Vaccines Administered to Healthy Adol Meningococcal Disease | Phase 2 | 2006-02-01 |
| Completed | Immunogenicity, Safety, Tolerability and Ability to Prime for Memory of Meningococcal C Conjugate Vaccine in H Prevention of Meningococcal Infection | Phase 3 | 2005-10-01 |
| Completed | Study of the Safety and Immunogenicity of an Influenza Vaccine Administered to Healthy Adults Influenza Disease; Flu | Phase 2 | 2005-10-01 |
| Completed | Safety and Immunogenicity of 3 Lots of Cell-derived Subunit Influenza Vaccine as Compared to 1 Lot to Egg-deri Influenza | Phase 3 | 2005-09-01 |
| Completed | Comparison of Safety, Tolerability and Immunogenicity of Influenza Vaccines in Adults and Elderly Influenza | Phase 3 | 2005-09-01 |
| Completed | Immunogenicity and Safety of MenACWY in Infants (6 & 12 Months) Meningococcal Meningitis | Phase 2 | 2005-06-01 |
| Completed | Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Children Prevention of Meningococcal Disease | Phase 2 | 2005-04-01 |
| Completed | Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Children Aged 12-59 Mont Meningococcal Meningitis | Phase 2 | 2005-03-01 |
| Completed | Persistence of Antibody Response to N. Meningitidis Group C in Children Prevention of Meningococcal Infection | Phase 4 | 2005-02-01 |
| Completed | Study of the Safety and Immune Response of a Meningococcal Conjugate Vaccine Administered to Healthy Adolescen Prevention of Meningococcal Disease | Phase 2 | 2004-10-01 |
| Completed | Safety and Immunogenicity of a Cell Culture-derived Influenza Vaccine in Healthy Adults and Elderly Influenza | Phase 3 | 2004-09-01 |
| Completed | Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Infants Prevention of Meningococcal Disease | Phase 2 | 2004-09-01 |
| Completed | Safety and Immunogenicity of Chiron's Investigational H. Pylori Vaccine in Healthy Adults Helicobacter Pylori, Gastritis, Gastric Cancer | Phase 1 | 2001-02-01 |